Urology · 2026
Fear and Health Behavior: The Association Between Fear of Cancer Recurrence and Smoking Cessation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Golomb Dor, Simard Sébastien, Eisner Alon, Avda Yuval, Atamna Fahed, Raz Orit
Аннотация
OBJECTIVE: To evaluate the impact of fear of cancer recurrence (FCR) on smoking cessation in patients diagnosed with bladder tumors. This study explores its potential role as a motivator for behavioral changes, specifically tobacco abstinence.
SUBJECTS AND METHODS: A total of 79 patients undergoing surgical intervention for tumor treatment were included in this cross-sectional study. Smoking history and the specific motivation for cessation were documented. FCR was assessed using the Fear of Cancer Recurrence Inventory - Short Form (FCRI-SF). Statistical analysis was performed to compare FCRI-SF scores between patients who achieved smoking cessation due to their diagnosis and those who did not.
RESULTS: The median age of the cohort was 55.4 years (IQR 48.0-65.5). Among the 35 patients (44.3%) with a smoking history, 12 (34.3%) successfully achieved smoking cessation specifically attributed to their tumor diagnosis. These patients reported significantly higher FCRI-SF scores (M = 24.08, SD = 4.01) compared to the non-cessation group (M = 13.04, SD = 7.75; P <.001). Notably, 100% of the patients who quit smoking reached the clinical threshold for FCR (≥13), compared to only 43.5% of those who continued smoking. High frequency of intrusive thoughts and elevated perceived risk of recurrence were the most significant drivers for those who quit.
CONCLUSION: Higher levels of FCR are strongly associated with successful smoking cessation following a tumor diagnosis. Our findings suggest that clinical FCR may serve as a critical "teachable moment" for health behavior modification. Integrating smoking cessation programs into the psychological management of patients with high FCR could enhance long-term oncology outcomes.
SUBJECTS AND METHODS: A total of 79 patients undergoing surgical intervention for tumor treatment were included in this cross-sectional study. Smoking history and the specific motivation for cessation were documented. FCR was assessed using the Fear of Cancer Recurrence Inventory - Short Form (FCRI-SF). Statistical analysis was performed to compare FCRI-SF scores between patients who achieved smoking cessation due to their diagnosis and those who did not.
RESULTS: The median age of the cohort was 55.4 years (IQR 48.0-65.5). Among the 35 patients (44.3%) with a smoking history, 12 (34.3%) successfully achieved smoking cessation specifically attributed to their tumor diagnosis. These patients reported significantly higher FCRI-SF scores (M = 24.08, SD = 4.01) compared to the non-cessation group (M = 13.04, SD = 7.75; P <.001). Notably, 100% of the patients who quit smoking reached the clinical threshold for FCR (≥13), compared to only 43.5% of those who continued smoking. High frequency of intrusive thoughts and elevated perceived risk of recurrence were the most significant drivers for those who quit.
CONCLUSION: Higher levels of FCR are strongly associated with successful smoking cessation following a tumor diagnosis. Our findings suggest that clinical FCR may serve as a critical "teachable moment" for health behavior modification. Integrating smoking cessation programs into the psychological management of patients with high FCR could enhance long-term oncology outcomes.